Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lack of effect of tart cherry concentrate dose on serum urate in people with gout.

  • 2019-12-31
  • Rheumatology (Oxford, England) 59(9)
    • Lisa K Stamp
    • Peter Chapman
    • Christopher Frampton
    • Stephen B Duffull
    • Jill Drake
    • Yuqing Zhang
    • Tuhina Neogi

Study Design

Type
Randomized Controlled Trial (RCT)
Population
Fifty people with gout and SU > 0.36 mmol/l
Methods
Randomized to receive tart cherry juice concentrate: placebo, 7.5 ml, 15 ml, 22.5 ml or 30 ml twice daily for 28 days. Blood samples at baseline, then at 1, 3 and 5 h post cherry and on days 1, 3, 7, 14, 21 and 28.
Duration
28 days
Funding
Unclear

Objectives

Cherry concentrate has been suggested to reduce serum urate (SU) and gout flares. The aims of this study were to determine the magnitude of the effect of tart cherry concentrate on SU in people with gout, the most effective dose of tart cherry concentrate for lowering SU, and adverse effects.

Methods

Fifty people with gout and SU > 0.36 mmol/l were recruited. Half were on allopurinol and half were on no urate-lowering therapy. Participants were randomized to receive tart cherry juice concentrate: placebo, 7.5 ml, 15 ml, 22.5 ml or 30 ml twice daily for 28 days. Blood samples were taken at baseline, then at 1, 3 and 5 h post cherry and then on days 1, 3, 7, 14, 21 and 28. The area under the curve for SU was calculated over the 28-day study period.

Results

Cherry concentrate dose had no significant effect on reduction in SU area under the curve, urine urate excretion, change in urinary anthocyanin between day 0 and day 28, or frequency of gout flares over the 28-day study period (P = 0.76). There were 24 reported adverse events, with only one (hyperglycaemia) considered possibly to be related to cherry concentrate. Allopurinol use did not modify the effect of cherry on SU or urine urate excretion.

Conclusion

Tart cherry concentrate had no effect on SU or urine urate excretion. If there is an effect of cherry concentrate on gout flares over a longer time period, it is not likely to be mediated by reduction in SU.

Trial registration

Australian New Zealand Clinical Trials Registry (ANZCTR), https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=368887, ANZCTR 12615000741583).

Research Insights

  • no significant effect on ... frequency of gout flares over the 28-day study period (P = 0.76)

    Effect
    Neutral
    Effect size
    Small
    Dose
    7.5 ml, 15 ml, 22.5 ml, or 30 ml twice daily
  • no significant effect on ... change in urinary anthocyanin between day 0 and day 28

    Effect
    Neutral
    Effect size
    Small
    Dose
    7.5 ml, 15 ml, 22.5 ml, or 30 ml twice daily
  • Cherry concentrate dose had no significant effect on reduction in SU area under the curve, urine urate excretion

    Effect
    Neutral
    Effect size
    Small
    Dose
    7.5 ml, 15 ml, 22.5 ml, or 30 ml twice daily

Adverse Events Reported

  • tart cherryhyperglycemia

    There were 24 reported adverse events, with only one (hyperglycaemia) considered possibly to be related to cherry concentrate.

    Finding
    Reported
Back to top